Abstract
Context The Edmonton Symptom Assessment System-revised (ESAS-r) is a brief and widely used symptom measurement tool. Objectives To validate the Japanese version of the ESAS-r in Japanese patients with cancer. Methods We assessed the internal consistency, test-retest reliability, concurrent validity, and known-group validity in 292 Japanese adult patients with cancer. They completed Japanese versions of the ESAS-r, M. D. Anderson Symptom Inventory, and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30. Results Cronbach's alpha coefficient of the Japanese version of the ESAS-r was 0.87. The intraclass correlation coefficient in the test-retest examination ranged from 0.82 to 0.91 for each symptom score and was 0.90 for the total score. Pearson correlation coefficients of each ESAS-r symptom score with corresponding M. D. Anderson Symptom Inventory and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 items ranged from 0.45 to 0.80. The total score of the ESAS-r was significantly higher in patients with an Eastern Cooperative Oncology Group performance status of 2-4 than in those with a performance status of 0 and 1 (P <0.0001). Conclusion The Japanese version of the ESAS-r is a reliable and valid tool for measuring symptoms in Japanese adult patients with cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 718-723 |
| Number of pages | 6 |
| Journal | Journal of Pain and Symptom Management |
| Volume | 50 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - Nov 1 2015 |
Fingerprint
Keywords
- Edmonton Symptom Assessment System
- Edmonton Symptom Assessment System-revised
- reliability
- symptom assessment
- validation
- validity
ASJC Scopus subject areas
- Anesthesiology and Pain Medicine
- Clinical Neurology
- Nursing(all)
Cite this
Validation of the Japanese Version of the Edmonton Symptom Assessment System-Revised. / Yokomichi, Naosuke; Morita, Tatsuya; Nitto, Akihiro; Takahashi, Naoko; Miyamoto, Shingo; Nishie, Hiroyuki; Matsuoka, Junji; Sakurai, Hiroki; Ishihara, Tatsuhiko; Mori, Masanori; Tarumi, Yoko; Ogawa, Asao.
In: Journal of Pain and Symptom Management, Vol. 50, No. 5, 01.11.2015, p. 718-723.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Validation of the Japanese Version of the Edmonton Symptom Assessment System-Revised
AU - Yokomichi, Naosuke
AU - Morita, Tatsuya
AU - Nitto, Akihiro
AU - Takahashi, Naoko
AU - Miyamoto, Shingo
AU - Nishie, Hiroyuki
AU - Matsuoka, Junji
AU - Sakurai, Hiroki
AU - Ishihara, Tatsuhiko
AU - Mori, Masanori
AU - Tarumi, Yoko
AU - Ogawa, Asao
PY - 2015/11/1
Y1 - 2015/11/1
N2 - Context The Edmonton Symptom Assessment System-revised (ESAS-r) is a brief and widely used symptom measurement tool. Objectives To validate the Japanese version of the ESAS-r in Japanese patients with cancer. Methods We assessed the internal consistency, test-retest reliability, concurrent validity, and known-group validity in 292 Japanese adult patients with cancer. They completed Japanese versions of the ESAS-r, M. D. Anderson Symptom Inventory, and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30. Results Cronbach's alpha coefficient of the Japanese version of the ESAS-r was 0.87. The intraclass correlation coefficient in the test-retest examination ranged from 0.82 to 0.91 for each symptom score and was 0.90 for the total score. Pearson correlation coefficients of each ESAS-r symptom score with corresponding M. D. Anderson Symptom Inventory and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 items ranged from 0.45 to 0.80. The total score of the ESAS-r was significantly higher in patients with an Eastern Cooperative Oncology Group performance status of 2-4 than in those with a performance status of 0 and 1 (P <0.0001). Conclusion The Japanese version of the ESAS-r is a reliable and valid tool for measuring symptoms in Japanese adult patients with cancer.
AB - Context The Edmonton Symptom Assessment System-revised (ESAS-r) is a brief and widely used symptom measurement tool. Objectives To validate the Japanese version of the ESAS-r in Japanese patients with cancer. Methods We assessed the internal consistency, test-retest reliability, concurrent validity, and known-group validity in 292 Japanese adult patients with cancer. They completed Japanese versions of the ESAS-r, M. D. Anderson Symptom Inventory, and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30. Results Cronbach's alpha coefficient of the Japanese version of the ESAS-r was 0.87. The intraclass correlation coefficient in the test-retest examination ranged from 0.82 to 0.91 for each symptom score and was 0.90 for the total score. Pearson correlation coefficients of each ESAS-r symptom score with corresponding M. D. Anderson Symptom Inventory and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 items ranged from 0.45 to 0.80. The total score of the ESAS-r was significantly higher in patients with an Eastern Cooperative Oncology Group performance status of 2-4 than in those with a performance status of 0 and 1 (P <0.0001). Conclusion The Japanese version of the ESAS-r is a reliable and valid tool for measuring symptoms in Japanese adult patients with cancer.
KW - Edmonton Symptom Assessment System
KW - Edmonton Symptom Assessment System-revised
KW - reliability
KW - symptom assessment
KW - validation
KW - validity
UR - http://www.scopus.com/inward/record.url?scp=84945449320&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84945449320&partnerID=8YFLogxK
U2 - 10.1016/j.jpainsymman.2015.05.014
DO - 10.1016/j.jpainsymman.2015.05.014
M3 - Article
C2 - 26169339
AN - SCOPUS:84945449320
VL - 50
SP - 718
EP - 723
JO - Journal of Pain and Symptom Management
JF - Journal of Pain and Symptom Management
SN - 0885-3924
IS - 5
ER -